Thank you for your continued loyalty and trust in Cmed and encapsia during these uncertain times. We are continuously monitoring the evolving circumstances surrounding the COVID-19 outbreak and continue to operate as normal. ~ Our highest priority is to maintain the health and safety of our people, customers, partners and suppliers while meeting our service commitments. Cmed has implemented a range of measures in line with World Health Organization guidance to minimise the risks for employees and customers. Business Continuity procedures have been in place since 10th March 2020 and the Cmed Management Committee meets on a daily basis to monitor the situation.

Despite the recent issues in many countries, we are still able to provide technology solutions for all our customers as normal. During these difficult times, encapsia continues to operate with 100% uptime. We are proud to offer industry leading software and features to give our customers the utmost flexibility to allow their studies to continue through all eventualities.

We believe we are all in this together and will continue to follow our Cmed Guiding Principle: 
We are one team.

Learn how encapsia can help you!

To book a no-obligation meeting or demonstration please get in touch by using the contact form below:

Contact us

Latest articles

Minimizing Disruption Through Hybrid Clinical Trial Adoption

There have been significant disruptions in the healthcare industry in recent years, particularly in the conduct of clinical trials. The traditional, centralized model of clinical trial design has faced significant challenges in terms of patient recruitment, retention, and overall operational…

Read article

Employee Spotlight: Women in Tech

Q&A with encapsia’s Executive Director of Business Development Temitope Keyes   Superior innovation and performance are achieved with diverse teams that bring new perspectives and skill sets. In acknowledgment of International Women’s Day, we’re shining the spotlight on women in…

Read article

Delayed Clinical Data and Its Impact

The increasing complexity of modern trials demands more intensive data capture. Innovative study designs seek to minimize patient exposure to potential risks, improve convenience and shorten therapy time-to-market —requiring collecting and assimilating more data points than ever before. Data now…

Read article